Industry leaders and startup companies in the pharmaceutical, biotechnology, and medical device industry need clinical solutions that are affordable, specialized, and dedicated to their company’s success. That’s where we come in. We partner with you, through alignment on cost, quality, and performance, and commit to supporting you deliver on your goals and improve your processes so you can concentrate on what you do best: provide high-quality care for patients.
Our partnership model is rooted in listening and true collaboration to maximize the value of what we bring to you
Your Mission is Our Mission.
Avila Clinical Consulting is passionate about improving patients’ lives. You will benefit from our deep experience and innovative thinking, which will help you run your clinical studies smoothly and with the high quality you expect.
Let our commitment to you support your commitment to patients, and together we can help your team achieve success and accelerate treatment delivery to patients.
Leticia Tarilonte, MS.
Founder and Principal Consultant
Leticia has over 23 years of industry experience managing several research projects and clinical studies in various roles.
She started her career in Pharma at Biogen, working collaboratively in an integrated monoclonal antibody research team for 7 years, and then moving to development in clinical operations, where she managed numerous phase I-III clinical trials in diverse therapeutic areas including, gastroenterology, immunology, neurology, and neuropathic pain.
She continued her career at Merck KGaA/EMD Serono where she held various roles in Clinical Development providing strategic and operational expertise in the planning and conduct of Phase I-III clinical studies in neurology, oncology and immuno-oncology, contributing to the BLA submission of BAVENCIO®, which led to the FDA accelerated approval in merkel cell carcinoma and in urothelial carcinoma. Later she functioned as a Chief of Staff, where she partnered with executives to identify and promote projects that are of strategic importance to the company and translate the function strategy into operational plans.
After almost 20 years in Pharma, Leticia then joined a variety of biotech companies addressing the significant unmet need for rare diseases and rare cancers. In her last role, Leticia is the Vice-President of Global Clinical Operations at Brainstorm Cell Therapeutics, a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases.. Leticia has been recognized for her ability to build the Clinical Operations Team, and achieve clinical program objectives within established timelines, budget, and quality standards, while fostering a highly collaborative culture and serving as a leadership role model.
She also serves as an IRB member at Yale University and in 2023 she took on the role of President and Chair of the Association of Clinical Research Professionals - New England Chapter.
Leticia earned her Bachelor’s Degree in Biomedical Laboratory and Clinical Sciences from the School of Medicine at Boston University, followed by a Master’s Degree in Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and Health Sciences in Boston.
Strategic and operational expertise in the planning and conduct of Phase I-III clinical studies, ISS and EAP. Held leadership roles in several NDA and BLA approvals, including inspection readiness and various FDA, EMA and PMDA inspections.
Recognized as being curious and inquisitive, able to think of new solutions, knowledgeable, thorough, rigorous, proactive, decisive, inclusive, empathetic, and a positive, influential leader.
Experienced in developing high-functioning, collaborative Clinical Operations teams. Responsible for resource allocation, planning and budget for projects and teams.
Thrive working in high pace environments as independent leader, capable of managing various programs with numerous clinical trials while driving progress towards goals under stringent deadlines.